Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Jiangxia Blood Technology specializes in the research, development, and commercialization of blood therapy technologies. The company has developed patented plasma lipid filtration devices for clinical use in treating high blood lipid conditions that are not suitable for drug treatment. Their products are used to remove excess plasma lipids and improve patient outcomes in related indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Jiangxia Blood Technology.